CoreWeave (NASDAQ:CRWV – Get Free Report) and Axe Compute (NASDAQ:AGPU – Get Free Report) are both technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, valuation and analyst recommendations.
Analyst Ratings
This is a summary of current ratings and recommmendations for CoreWeave and Axe Compute, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| CoreWeave | 4 | 7 | 27 | 0 | 2.61 |
| Axe Compute | 1 | 0 | 0 | 1 | 2.50 |
CoreWeave presently has a consensus price target of $129.41, indicating a potential upside of 192.14%. Given CoreWeave’s stronger consensus rating and higher possible upside, equities analysts clearly believe CoreWeave is more favorable than Axe Compute.
Profitability
This table compares CoreWeave and Axe Compute’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| CoreWeave | -25.41% | -47.95% | -3.79% |
| Axe Compute | -7,769.61% | -1,606.56% | -355.39% |
Insider & Institutional Ownership
9.0% of Axe Compute shares are owned by institutional investors. 24.2% of CoreWeave shares are owned by insiders. Comparatively, 1.2% of Axe Compute shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares CoreWeave and Axe Compute”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| CoreWeave | $5.13 billion | 3.96 | -$1.17 billion | ($3.65) | -12.14 |
| Axe Compute | $120,000.00 | 650.20 | -$233.10 million | ($5.75) | -1.17 |
Axe Compute has lower revenue, but higher earnings than CoreWeave. CoreWeave is trading at a lower price-to-earnings ratio than Axe Compute, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
CoreWeave has a beta of 7.71, indicating that its share price is 671% more volatile than the S&P 500. Comparatively, Axe Compute has a beta of 3.84, indicating that its share price is 284% more volatile than the S&P 500.
Summary
CoreWeave beats Axe Compute on 10 of the 15 factors compared between the two stocks.
About CoreWeave
CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.
About Axe Compute
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient’s body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.
Receive News & Ratings for CoreWeave Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CoreWeave and related companies with MarketBeat.com's FREE daily email newsletter.
